IRIS
SCARPELLI, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.356
EU - Europa 9.992
AS - Asia 9.194
SA - Sud America 2.208
AF - Africa 514
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 6
Totale 43.289
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.017
SG - Singapore 3.099
RU - Federazione Russa 2.429
VN - Vietnam 1.837
BR - Brasile 1.751
UA - Ucraina 1.573
CN - Cina 1.227
IE - Irlanda 999
HK - Hong Kong 923
DE - Germania 905
IT - Italia 871
SE - Svezia 870
TR - Turchia 813
FR - Francia 608
DK - Danimarca 576
FI - Finlandia 409
GB - Regno Unito 391
KR - Corea 325
IN - India 247
CI - Costa d'Avorio 229
CA - Canada 162
AR - Argentina 156
BD - Bangladesh 134
MX - Messico 127
NL - Olanda 88
EC - Ecuador 84
ID - Indonesia 81
ZA - Sudafrica 80
IQ - Iraq 78
MA - Marocco 68
CO - Colombia 63
JP - Giappone 62
PL - Polonia 58
PK - Pakistan 51
VE - Venezuela 48
ES - Italia 45
UZ - Uzbekistan 42
PH - Filippine 39
BE - Belgio 37
SA - Arabia Saudita 29
CL - Cile 28
TN - Tunisia 28
PY - Paraguay 27
EG - Egitto 24
DZ - Algeria 22
AE - Emirati Arabi Uniti 20
AT - Austria 20
MY - Malesia 20
TH - Thailandia 20
PE - Perù 19
EE - Estonia 18
JO - Giordania 18
RO - Romania 18
EU - Europa 17
KE - Kenya 16
BO - Bolivia 15
KZ - Kazakistan 15
UY - Uruguay 14
ET - Etiopia 13
TW - Taiwan 13
AZ - Azerbaigian 11
BH - Bahrain 11
NP - Nepal 11
CZ - Repubblica Ceca 10
OM - Oman 10
IL - Israele 9
LB - Libano 9
CR - Costa Rica 8
AL - Albania 7
AO - Angola 7
BG - Bulgaria 7
GR - Grecia 7
KG - Kirghizistan 7
LT - Lituania 7
AU - Australia 6
HN - Honduras 6
SY - Repubblica araba siriana 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
NG - Nigeria 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BY - Bielorussia 4
IR - Iran 4
PA - Panama 4
PS - Palestinian Territory 4
PT - Portogallo 4
SN - Senegal 4
GE - Georgia 3
JM - Giamaica 3
MD - Moldavia 3
ML - Mali 3
MU - Mauritius 3
NI - Nicaragua 3
PR - Porto Rico 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BN - Brunei Darussalam 2
Totale 43.238
Salva come PNG Salva come JPEG
Città #
Ashburn 3.047
Singapore 2.022
Chandler 1.751
Jacksonville 1.635
Fairfield 1.437
Des Moines 1.204
Dallas 1.132
Dublin 997
Boardman 906
Hong Kong 888
Wilmington 816
San Jose 742
Woodbridge 642
Ho Chi Minh City 605
Seattle 583
Houston 570
New York 548
Cambridge 426
The Dalles 415
Hanoi 408
Lawrence 402
Princeton 402
San Mateo 390
Lauterbourg 360
Beijing 305
Ann Arbor 290
Moscow 266
Los Angeles 236
Abidjan 229
Centro 213
San Diego 178
Hefei 177
Milan 170
São Paulo 151
Munich 116
London 99
Haiphong 95
Da Nang 92
Chicago 90
Pune 78
Helsinki 74
Orem 72
Santa Clara 71
Buffalo 69
Council Bluffs 67
Washington 62
Mexico City 61
Shanghai 57
Turku 53
Tokyo 52
Rio de Janeiro 50
Warsaw 48
Redmond 47
Vancouver 46
Frankfurt am Main 45
Guangzhou 45
Norwalk 44
Columbus 42
Montreal 41
Tashkent 40
Turin 40
Izmir 39
Wuhan 39
Baghdad 38
Brooklyn 38
Curitiba 38
Johannesburg 37
Atlanta 36
Salt Lake City 35
Brussels 34
Guayaquil 34
Amsterdam 33
Chennai 33
Manchester 33
Denver 32
Porto Alegre 31
Ancona 29
Falls Church 29
Phoenix 29
Elk Grove Village 28
Belo Horizonte 27
Biên Hòa 26
Hải Dương 26
San Francisco 26
Brasília 25
Stockholm 25
Can Tho 24
Dhaka 24
Jiaxing 23
Thái Nguyên 23
Campinas 22
Poplar 21
Quito 21
New Delhi 20
Quận Ba 20
Rome 20
Thái Bình 20
Istanbul 19
Marche 19
Mumbai 19
Totale 27.334
Salva come PNG Salva come JPEG
Nome #
Role of electron microscopy in the diagnosis of CADASIL syndrome: a study of 32 patients 759
Metabolic phenotype of bladder cancer 251
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 213
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 210
Immunotherapy in genitourinary cancers: Where are we going? 205
Prostatic Intraepithelial Neoplasia - Development of A Bayesian Belief Network For Diagnosis and Grading. 201
Are liver nested stromal epithelial tumors always low aggressive? 198
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 194
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 193
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 190
2004 WHO classification of the renal tumors of the adults. 189
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: Molecular diagnostics and possible targets for personalized therapies 187
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 186
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia 181
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 177
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 176
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 176
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 172
Re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790–807 171
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer 170
A rare case of chordoma and craniopharyngioma treated by an endoscopic endonasal, transtubercular transclival approach. 169
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 166
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 166
Secondary neoplasms of the urinary system and male genital organs. 165
Standardized mitotic counts in breast cancer evaluation of the method 165
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 164
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 161
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 160
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 159
Endoscopy-verified occult subependymal dissemination of glioblastoma and brain metastasis undetected by MRI: prognostic significance. 158
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies 158
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 157
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 156
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 156
HER family receptor expression and prognosis in pancreatic cancer 156
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 155
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy 153
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 153
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 152
Microbiome and cancers, with focus on genitourinary tumors 152
Active surveillance for low-risk prostate cancer. 150
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer 150
Seminoma Retroperitoneal Relapse 23 Years After Surgery 150
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 149
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 149
Metabolic Alterations in Renal and Prostate Cancer 148
Meningioma-like cerebral relapse of Hodgkin's disease. 145
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 144
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 144
Bone targeting agents in patients with metastatic prostate cancer: State of the art 144
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 143
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 142
The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions 142
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? 142
Subarachnoid haemorrhage due to widely metastatising malignant ependymoma. 140
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 140
Genitourinary cancers: molecular determinants for personalized therapies 139
Is There a Role for Immunotherapy in Prostate Cancer? 139
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 138
2009 update on the classification of renal epithelial tumors in adults 138
[Magnetic resonance in the pathologic evaluation of the isolated human brain]. 138
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer 138
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 138
Angioblastic parasellar extradural tumours. 137
Rare synchronous association of vestibular schwannoma and indolent insular oligodendroglioma in a patient without neurofibromatosis: controversial issue of timing for surgical treatment of asymptomatic low-grade gliomas. 137
Epileptogenic Low-Grade Tumours in Childhood: Outcome after Lesionectomy 136
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 136
MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. 135
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 135
A contemporary update on pathology reporting for urinary bladder cancer. 133
Bladder cancer: molecular determinants of personalized therapy 133
A low grade PIN-like neoplasm of the transition zone immunohistochemically negative for basal cell markers: a possible example of low grade adenocarcinoma with stratified epithelium. 132
Pd-l1 inhibitors for the treatment of prostate cancer 132
Seminal Vesicle Intraepithelial Neoplasia Versus Basal Cell Hyperplasia in a Seminal Vesicle. 131
An overview of emerging immunotargets of genitourinary tumors 130
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies 130
Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers 130
Computer assisted discrimination of glioblastomas 130
Mitochondrial encephalomyopathy lactic acidosis and strokelike episodes mimicking occipital idiopathic epilepsy. 129
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading 128
Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors 128
Epigenetic modifications and modulators in prostate cancer 128
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 127
Morphological diagnosis of urothelial neoplasms. 127
"No pay, no play" or from "defensive or passive pathology" to "active, clinically oriented pathology" 127
Present and future of personalized medicine in adult genitourinary tumors 127
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View 127
Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur. 127
[Intracranial pressure in traumatic brain laceration and intracerebral hematomas (author's transl)]. 126
The identification of immunological biomarkers in kidney cancers 126
New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials 126
Cardiac myxoma with glandular elements metastatic to the brain 12 years after the removal of the original tumor 125
TGFb1 immunohistochemistry in goiter; comparison of patients with recurrence or non recurrence 125
Quantitative-analysis of Prostatic Intraepithelial Neoplasia On Tissue-sections. 125
SURGICAL TREATMENT FOR GLIOBLASTOMA MULTIFORME: OUTCOME AND ANALYSIS OF PROGNOSTIC FACTORS ESPECIALLY ORIENTED TO THE EXTENT OF SURGICAL RESECTION 125
From undergraduate medical school student to visible pathologist 125
Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report 124
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 124
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma 123
Immunotherapy in renal cell carcinoma: latest evidence and clinical implications 123
Totale 15.639
Salva come PNG Salva come JPEG
Categoria #
all - tutte 203.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.349
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.356 0 0 0 0 0 0 0 0 0 552 572 232
2021/20223.031 317 620 95 136 28 269 82 202 192 273 190 627
2022/20235.798 523 459 326 462 379 1.580 3 350 1.303 34 267 112
2023/20243.068 555 78 200 429 510 696 53 75 6 53 26 387
2024/20256.021 657 522 240 141 214 222 560 262 1.535 462 505 701
2025/202614.799 787 1.103 1.098 1.586 1.508 1.030 2.752 1.669 2.067 1.199 0 0
Totale 43.701